• Trilaurin: From Lipid Structure to Assay Decisions

  2026-09-23

  Trilaurin (Glycerol Tridodecanoate) is more than a lipid ingredient: its C12 structure creates useful formulation properties and a distinct result in a mouse skin-sensitization model. This article connects that evidence to practical decisions in immunotoxicology, biocatalysis, and oral lipid delivery—without treating findings from one field as proof in another.

• Serial LNP-mRNA Delivery for Human T Cell Engineering

  2026-09-23

  Ramamurthy and colleagues show that DOTAP/DOPE lipid nanoparticles can repeatedly deliver synthetic mRNA to primary human T cells while preserving substantially more viable cells than electroporation. The pre-proof study establishes serial LNP transfection as a practical platform for iterative engineering, including the generation of functional CAR T cells, while leaving the intracellular trafficking mechanisms open for further investigation.

• How Cortical Ensembles Support Remote Memory

  2026-09-22

  DeNardo and colleagues used the TRAP2 activity-labeling system to show that prelimbic cortical ensembles reorganize over time rather than remaining fixed from learning through remote fear-memory retrieval. The study combines causal manipulation, activity mapping, and whole-brain projection analysis to link temporal ensemble dynamics with behavioral retrieval and downstream cortical recruitment.

• Tacalcitol Sensitizes Colorectal Cancer to 5-FU

  2026-09-22

  The reference study identifies a VDR–CDKN1A–thymidylate synthase pathway through which tacalcitol, a synthetic analog of vitamin D3, increases the response of HT-29 colorectal cancer cells to 5-fluorouracil. Its findings connect vitamin D receptor signaling with p21 induction, epithelial differentiation markers, survivin suppression, and reduced thymidylate synthase expression, providing a mechanistic basis for combination treatment research.

• Drug-Sensitized Yeast for mTOR Inhibitor Discovery

  2026-09-21

  The 2025 GeroScience study introduces a genetically drug-sensitized Saccharomyces cerevisiae platform that detects TOR pathway inhibition at substantially lower concentrations than a wild-type background. Its comparative design identifies known TOR inhibitors and aminophylline while distinguishing compounds, including nebivolol, that produced no TOR-dependent growth signal in this model.

• Cdc42-Driven Signaling in Kidney Fibrosis

  2026-09-21

  The reference study identifies daphnepedunin A as a natural anti-fibrotic lead that directly targets Cdc42 and disrupts downstream PKCζ/GSK-3β/β-catenin signaling. Its combination of chemical discovery, target deconvolution, renal fibroblast assays, and unilateral ureteral obstruction models provides a useful framework for evaluating Cdc42-directed interventions in chronic kidney disease.

• Cell Lysis Buffer for WB and IP in PCa Research

  2026-09-20

  Cell lysis buffer for WB and IP supports non-denaturing protein extraction for Western blot and immunoprecipitation workflows. Its Tris–NaCl–Triton X-100 formulation and inhibitor system can help preserve protein abundance, phosphorylation state, and native interactions when samples are handled under validated conditions.

• Acetylcysteine in Redox-Guided Cancer Assays

  2026-09-19

  Acetylcysteine can function as more than a glutathione precursor: it is a reversible redox probe for interpreting complex cancer nanomedicine assays. This article connects N-acetyl-L-cysteine chemistry with the photothermal and immune-remodeling strategy reported for metastatic triple-negative breast cancer.

• Trilaurin Workflows for Biocatalysis and Drug Delivery

  2026-09-18

  Trilaurin, also called Glycerol Tridodecanoate, connects renewable-feedstock biocatalysis with lipid-based oral delivery. This practical guide covers substrate preparation, formulation screening, assay controls, and troubleshooting for reproducible bench workflows.

• Perphenazine B6157: Reliable Cell Assays

  2026-09-18

  Perphenazine (SKU B6157) offers a practical, data-grounded tool for dopamine receptor antagonist research, mitochondrial cell-death studies, and selected host-directed infection workflows. This scenario-based guide explains solvent handling, assay design, interpretation, and supplier-selection considerations for more reproducible laboratory work.

• WSP-5: From H2S Signal to Cardiac Mechanism

  2026-09-17

  WSP-5, or Washington State Probe-5, translates reactive hydrogen sulfide chemistry into a rapid fluorescent readout. This article explains how to use that signal to strengthen mechanistic studies of lipotoxicity, ER stress, and diabetic cardiomyopathy.

• Sisomicin: 30S-Targeting Aminoglycoside

  2026-09-17

  Sisomicin is a broad-spectrum aminoglycoside antibiotic that inhibits bacterial protein synthesis through interaction with the 30S ribosomal subunit. Its research profile includes Gram-negative and Gram-positive activity, defined in vitro testing ranges, animal-model dosing information, and important renal, ototoxicity, nephrotoxicity, and resistance limitations.

• Urolithin A: Mitochondrial Readouts in Fibrosis

  2026-09-16

  Urolithin A can help dissect mitochondrial quality control from glutamine-driven hepatic stellate cell activation. This article presents a mechanism-aware assay strategy that separates mitophagy, bioenergetics, proliferation, and antifibrotic interpretation.

• Myriocin in dAGE-Exposed Mice: AMPK–PGC1α

  2026-09-16

  A 2025 Nutrients study shows that Myriocin counteracts high dietary advanced glycation end product exposure in mice by coordinating hepatic lipid and glucose regulation with AMPK–PGC1α-dependent mitochondrial activation. The work positions sphingolipid inhibition as a mechanistically integrated strategy for studying obesity-related metabolic dysfunction, while remaining preclinical and model-specific.

• Phillygenin Signaling in Diabetic Nephropathy

  2026-09-15

  The reference study shows that phillygenin alleviates diabetic nephropathy-associated inflammation, podocyte injury, and apoptosis by modulating TLR4/MyD88/NF-κB and PI3K/AKT/GSK3β signaling. Its integrated use of high-glucose podocyte models, RNA sequencing, molecular validation, and db/db mice provides a mechanistic framework for evaluating phillygenin while highlighting the limitations of translating pathway-level findings to human disease.

7955 records 1/531 page Next 12345 下5页 Last page